Upon cisplatin treatment of the ovarian cancer cell lines Igrov-1 and A2780, we identified both, an enhanced AREG release as well as an increased AREG mRNA and protein expression in cell lysates. This evidence concerns the gene AREG and ovarian carcinoma.